Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Human papillomavirus (HPV)
Meningococcal disease
SAGE documentation
Scientific publications
2015
2010
Clear all
Type of publications
NITAG documentation
(33)
Reports
(2)
SAGE documentation
(7)
Scientific publications
(9)
Systematic reviews (SYSVAC)
(18)
Topics
GRADE table
(4)
Position paper
(2)
Available to download in languages
English (EN)
(15)
French (FR)
(7)
Portugese (PT)
(1)
Russian (RU)
(1)
Regions
Africa
(3)
Americas
(1)
Eastern Mediterranean
(1)
Europe
(1)
South-East Asia
(1)
Western Pacific
(2)
Countries
Diseases
Human papillomavirus (HPV)
(9)
Meningococcal disease
(7)
Cholera
(1)
Haemophilus influenzae type B
(4)
Hepatitis A
(1)
Japanese encephalitis
(10)
Malaria
(2)
Measles
(1)
Mumps
(1)
Pertussis
(4)
Rabies
(1)
Rotavirus
(1)
Rubella
(1)
Vaccine topics
Target population
Newborn
(3)
Publication date
2015
(9)
2010
(7)
2024
(4)
2022
(3)
2019
(1)
2018
(10)
2017
(11)
2014
(3)
2013
(1)
2011
(2)
2009
(2)
2008
(1)
16 results found
2015
∙
Milagritos D. Tapia, Samba O. Sow, Fadima Cheick Haidara, Fatoumata Diallo, Moussa Doumbia, Godwin C. Enwere, Gandhali Paranjape, Jacques Hervé, Marie-Pierre Préziosi
A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
2015
∙
Andromachi Karachaliou, Andrew J. K. Conlan, Marie-Pierre Préziosi, Caroline Trotter
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
2015
∙
WHO
Meningococcal A conjugate vaccine: updated guidance
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a single-dose MenA conjugate vaccination in immunocompetent children (9 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
2015
∙
WHO
Summary of WHO Position Papers - Recommendations for Interrupted or Delayed Routine Immunization
2015
∙
WHO
Summary of WHO Position Papers – Immunization of Health Care Workers
2010
∙
Joanne Langley, Tara Harris, Bryna Warshawsky, Shalini Desai, Mahnaz FarhangMehr, Shainoor Ismail
Canada’s National Advisory Committee on Immunization (NACI): Evidence-based decision-making on vaccines and immunization
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register